Eleonora Zaccarelli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 01, 2021
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer.
Journal: British journal of cancer
Published: February 28, 2019
Bevacizumab in ovarian cancer: A critical review of phase III studies.
Journal: Oncotarget
Published: June 11, 2016
Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.
Journal: Expert opinion on investigational drugs
Published: November 13, 2015
Triple-negative breast cancer: new perspectives for targeted therapies.
Journal: OncoTargets and therapy
Published: February 06, 2015
Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment.
Journal: Current cancer drug targets
Published: January 12, 2015
Angiogenesis and antiangiogenic agents in cervical cancer.
Journal: OncoTargets and therapy
Published: December 16, 2014
Triple-negative breast cancer: investigating potential molecular therapeutic target.
Journal: Expert opinion on therapeutic targets
Published: October 14, 2014
Plerixafor and autologous stem cell transplantation: impressive result in a chemoresistant testicular cancer patient treated with high-dose chemotherapy.
Journal: Anti-cancer drugs
Published: May 24, 2013
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer.
Journal: OncoTargets and therapy
Published: October 12, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026